Today's Daily Dose brings you news about ARCA biopharma's progress related to its COVID-19 drug candidate, ADC Therapeutics' submission of Loncastuximab tesirine BLA, BridgeBio's initiation of ADH1 study, ERYTECH Pharma's anticipated milestones, and the progress in Lipocine's NASH trial.
from RTT - Biotech https://ift.tt/2EqFw1M
via IFTTT
No comments:
Post a Comment